[en] NF-kappa B is a pleiotropic transcription factor which controls the expression of many genes and viruses. To date, there is good evidence, but no definitive proof, for its role in tumor formation and development of metastasis. To investigate the possibility that members of the NF-kappa B family could participate in the molecular control of the transformed and invasive phenotype, we examined the expression of these proteins in a variety of human tumor cell lines. The expression of p50, p65, p52 and I kappa B was quantified at the protein level using western immunoblot and mobility shift assay and at the RNA level by northern blot. We observed high expression of the NF-kappa B inhibitor I kappa B in the ovarian carcinoma cell line OVCAR-3 together with constitutive nuclear NF-kappa B activity. We also studied the colon carcinoma cell line HT-29 and its metastatic counterpart HTM-29 and we observed specific expression of the p52 NF-kappa B-related protein in the metastatic cells. Our data confirm that NF-kappa B could be involved in the genesis of a variety of cancers including solid tumors and provide us with interesting models to explore the exact role of these transcription factors in cancer.
Disciplines :
Oncology
Author, co-author :
Bours, Vincent ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Génétique générale et humaine
Baeuerle (1991) The inducible transcription factor NF-κB: regulation by distinct protein subunit. Biochim Biophys Acta 1072:63-80.
Grilli, Chiu, Lenardo (1993) NF-κB and Rel participants in a multiform transcriptional regulatory system. Int Rev Cytol 148:1-63.
Greene (1990) Regulation of HIV-1 gene expression. Annu Rev Immunol 8:453-475.
Nabel, Baltimore (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711-713.
Blank, Kourilsky, Israel (1992) NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 17:135-140.
Nolan, Baltimore (1992) The inhibitory ankyrin and activator Rel proteins. Current Opinion in Genetics & Development 2:200-211.
Bours, Villalobos, Burd, Kelly, Siebenlist (1990) Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell cycle motifs. Nature 348:76-80.
Bours, Burd, Brown, Villalobos, Park, Ryseck, Bravo, Kelly, Siebenlist (1992) A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol Cell Biol 12:685-695.
Ghosh, Gifford, Riviere, Tempst, Nolan, Baltimore (1990) Cloning of the p50 binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019-1029.
Kieran, Blank, Logeat, Vandekerckhove, Lottspeich, Bail, Urgan, Kourilsky, Baeuerle, Israël (1990) The DNA-binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
Schmidt, Perkins, Duckett, Andrews, Nabel (1991) Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature 352:733-736.
Mercurio, Didonato, Rosette, Karin (1992) Molecular cloning and characterization of a novel rel/NF-κB family member displaying structural and functional analogy to NF-κB p50/p105. DNA Cell Biol 11:523-537.
Franzoso, Bours, Park, Tomita-Yamaguchi, Kelly, Siebenlist (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359:339-342.
Mercurio, DiDonato, Rosette, Karin (1993) p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Gene Dev 7:705-718.
Fan, Maniatis (1991) Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354:395-398.
Lux, John, Bennett (1990) Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344:36-42.
Ballard, Dixon, Peffer, Bogerd, Doerre, Stein, Greene (1992) The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA 89:1875-1879.
Nolan, Ghosh, Liou, Tempst, Baltimore (1991) DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961-969.
Ruben, Dillon, Schreck, Henkel, Chen, Maher, Baeuerle, Rosen (1991) Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science 251:1490-1493.
Ryseck, Bull, Takamiya, Bours, Siebenlist, Dobrzanski, Bravo (1992) RelB, a new rel family transcription activator that can interact with p50-NF-κB. Mol Cell Biol 12:674-684.
Ruben, Klement, Coleman, Maher, Chen, Rosen (1992) I-Rel: a novel rel-related protein that inhibits NF-κB transcriptional activity. Gene Dev 6:745-760.
Dobrzanski, Ryseck, Bravo (1993) Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol Cell Biol 13:1572-1582.
Brownell, Mitereder, Ricer (1989) A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4:935-942.
Kamens, Richardson, Mosialos, Brent, Gilmore (1990) Oncogenic transformation by v-Rel requires an amino-terminal activation domain. Mol Cell Biol 10:2840-2847.
Haskill, Beg, Tompkins, Morris, Yurochko, Sampson-Johannes, Mondal, Ralph, Baldwin (1991) Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 65:1281-1289.
Inoue, Kerr, Kakizuka, Verma (1992) I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell 68:1109-1120.
Liou, Nolan, Ghosh, Fujita, Baltimore (1992) The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. EMBO J 11:3003-3009.
Ohno, Takimoto, McKeithan (1990) The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineaage determination and cell cycle control. Cell 60:991-997.
Naumann, Wulczyn, Scheidereit (1993) The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J 12:213-222.
Bours, Franzoso, Azarenko, Park, Kanno, Brown, Siebenlist (1993) The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729-739.
Moore, Bose (1988) Transformation of avian lymphoid cells by reticuloendotheliosis virus. Mutation Res 195:79-80.
Moore, Bose (1988) Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts. Virology 162:377-387.
Sylla, Temin (1986) Activation of oncogenicity of the c-rel proto-oncogene. Mol Cell Biol 6:4709-4716.
Liptay, Schmid, Perkins, Meltzer, Altherr, McPherson, Wasmuth, Nabel (1992) Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. Genomics 13:287-292.
Lu, Thompson, Gorski, Rice, Mayer, Yunis (1991) Alterations of the rel locus in human lymphoma. Oncogene 6:1235-1241.
Mathew, Murty, Dalla-Favera, Chaganti (1993) Chromosomal localization of genes encoding the transcription factors c-rel, NF-κBp50, NF-κBp65 and lyt-10 by fluorescence in situ hybridization. Oncogene 8:191-193.
Narayanan, Klement, Ruben, Higgins, Rosen (1992) Identification of a naturally occurring transforming variant of the p65 subunit of NF-kappa B. Science 256:367-370.
Ruben, Poteat, Tan, Kawakami, Roeder, Haseltine, Rosen (1988) Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science 241:89-91.
Ballard, Böhnlein, Lowenthal, Wano, Franza, Greene (1988) HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 241:1652-1655.
Kitajima, Shinohara, Bilakovics, Xu, Nerenberg (1992) Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258:1792-1795.
Ghersa, Hooft van Hiujsduinen, Whelan, DeLamarter (1992) Labile proteins play a dual role in the control of Endothelial Leukocyte Adhesion Molecule-1 (ELAM-1) gene regulation. J Biol Chem 267:19226-19232.
Iademarco, McQuillan, Rosen, Dean (1992) Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323-16329.
Voraberger, Schäfer, Stratowa (1991) Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. J Immunol 147:2777-2786.
Whelan, Ghersa, Hooft van Huijsduijnen, Gray, Chandra, Talabot, DeLamarter (1991) An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res 19:2645-2653.
Sato, Seiki (1993) Regulatory mechanisms of 92 kDa type IV collagenase gene expression which is associated with invasiveness in tumor cells. Oncogene 8:395-405.
Narayanan, Higgins, Perez, Coleman, Rosen (1993) Evidence for differential functions of the p50 and p65 subunits of NF-κB with a cell adhesion model. Mol Cell Biol 13:3802-3810.
Plaskin, Baeuerle, Eisenbach (1993) KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells. Journal of Experimental Medicine 177:1651-1662.
Brown, Park, Kanno, Franzoso, Sibenlist (1993) Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc Natl Acad Sci USA 90:2532-2536.
Baeuerle, Baltimore (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
Beg, Ruben, Scheinman, Haskill, Rosen, Baldwin (1992) IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Gene Dev 6:1899-1913.
Schmitz, Henkel, Baeuerle (1991) Proteins controlling the nuclear uptake of NF-κB, Rel and dorsal. Trends Cell Biol 1:130-137.
Zabel, Henkel, Dos Santo Silva, Baeuerle (1993) Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 12:201-211.
Sun, Ganchi, Ballard, Greene (1993) NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
Beg, Finco, Nantermet, Baldwin (1993) Tumor necrosis factor and interleukine-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol Cell Biol 13:3301-3310.
Link, Kerr, Schreck, Zabel, Verma, Baeuewrle (1992) Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem 267:239-246.
Ghosh, Baltimore (1990) Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682.
Fujiita, Nolan, Liou, Scott, Baltimore (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes & Development 7:1354-1363.
Morin, Gilmore (1992) The C terminus of the NF-χB p50 precursor and an IχB isoform contain transcription activation domains. Nucleic Acids Research 25:2453-2458.